Donald Bierer

USPTO Granted Patents = 15 (Patent Applications = 10)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 7.8

ph-index = 4

Forward Citations = 103(Granted Patents)

Location History:

Haan, DE (2013 - 2023)
Berlin, DE (2018 - 2024)

Company Filing History:

Bayer Pharma Aktiengesellschaft

patents

3 out of 12,157

Bayer Aktiengesellschaft

patents

4. 2 out of 721

Bayer Intellectual Property Gmbh

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12064429 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2024-08-20),

2. 11667675 - MASP inhibitory compounds and uses thereof (2023-06-06),

3. 11439642 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2022-09-13),

4. 11344519 - Orally administrable modified-release pharmaceutical dosage form (2022-05-31),

5. 10905667 - Orally administrable modified-release pharmaceutical dosage form (2021-02-02),

6. 10736896 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2020-08-11),

7. 10633356 - Hydrates of substituted 5-fluoro-1H-pyrazolopyridines (2020-04-28),

8. 10364229 - Crystalline substituted 5-fluoro-1H-pyrazolopyridines and process for preparing (2019-07-30),

9. 9993476 - Substituted 5-flouro-1H-pyrazolopyridines and their use (2018-06-12),

10. 9604948 - Process for preparing substituted 5-fluoro-1H-pyrazolopyridines (2017-03-28),

11. 9586958 - Prodrug derivatives of substituted triazolopyridines (2017-03-07),

12. 9422263 - Fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof (2016-08-23),

13. 9266885 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2016-02-23),

14. 8921377 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2014-12-30),

15. 8420656 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2013-04-16),

Title: Donald Bierer: Pioneering Innovator Shaping the Future of Medicine

Introduction:

Donald Bierer, a visionary inventor based in Haan, DE, is a prominent figure in the field of pharmaceutical innovation. His relentless drive to create impactful solutions has solidified his legacy as a leading inventor shaping the future of technology and medicine.

Latest Patents:

With an impressive portfolio of 14 patents, Donald Bierer continues to revolutionize the healthcare industry. His latest patents include groundbreaking inventions such as MASP inhibitory compounds and uses thereof, which are integral in the treatment and prevention of renal and cardiovascular disorders. Additionally, his work on substituted 5-fluoro-1H-pyrazolopyridines showcases his commitment to advancing treatments for cardiovascular diseases.

Career Highlights:

Throughout his career, Donald Bierer has made significant contributions to renowned companies such as Adverio Pharma GmbH and Bayer Pharma Aktiengesellschaft. His innovative spirit and dedication to scientific excellence have propelled him to the forefront of pharmaceutical research and development.

Collaborations:

Donald Bierer has collaborated closely with esteemed colleagues Markus Follmann and Johannes-Peter Stasch, further enhancing the impact of his groundbreaking inventions. Together, they have pioneered cutting-edge solutions that have the potential to revolutionize the way various diseases are treated and prevented.

Conclusion:

In conclusion, Donald Bierer's passion for innovation and his unwavering commitment to making a positive impact on society have established him as a visionary inventor reshaping the landscape of medicine. His groundbreaking patents and collaborative efforts underscore his relentless drive to advance healthcare solutions for the betterment of society and solidify his position as a leading figure in pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.